Inspire Medical Systems INSP · NYSE
$70.12 +1.93% (+$1.33)
Summary
78 / 100 · Bulios Score
What speaks for it
- Revenue grew by 31% a year over the last 3 years.
- Out of every 100 USD of revenue, 15 USD is left as net profit.
- It holds more cash than debt: $127.8M against $29.1M.
- The share price is below the Bulios Fair Price.
What to watch
- Analysts expect revenue to fall by 6.4% this fiscal year.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 14.7 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 51% a year over 5 years. Over the last 3 years it grew by 31% a year. For the next fiscal year analysts expect revenue to fall by 6.4%.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 14 USD
- Research and development 11 USD
- Sales and administration 69 USD
- Taxes and other -9.0 USD
- Net profit 15 USD
Net profit, industry median (Medical - Devices) 6.9 USD
Out of every 100 USD of revenue, 15 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 12
- Hold 16
- Sell 0
Today's price within the analysts' price targets
The average target of $62.3 is 11% below today's price. 43% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Operating Segment 100%
By region
- UNITED STATES 96%
- Non-US 4.4%
Operating Segment brings in 100% of revenue.
Segments in detail